Hamamatsu Pharma Research, Inc. (HPR) is a Japan-based preclinical CRO specializing in pharmacological efficacy studies using nonhuman primate (NHP) disease models. While rodent-based efficacy models are the cornerstone of preclinical discovery programs, few novel therapeutics based on rodent models have successfully completed clinical evaluation. As NHPs are phylogenetically and physiologically more similar to humans than rodents, our NHP efficacy models will help you to obtain preclinical POC relevant to clinical efficacy. Develop your novel therapeutics with HPR's NHP efficacy models. HPR is also open to collaborative opportunities with academic and corporate institutions.